Ingevity reports first quarter 2025 financial results

About this update from Ingevity Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2282,"height":928,"url":"https://media.zenfs.com/en/business-wire.com/40789b6061a8f36dffe822e7c5906726"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tYozp7OEY4O1kOlnb.5CBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM5MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/40789b6061a8f36dffe822e7c5906726","width":960,"height":390},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/rJ2tbYBo8xmHJWgDgMJiSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD05NzY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/40789b6061a8f36dffe822e7c5906726","width":1200,"height":488}},"lazy":false},{"type":"text","content":"HIGHLIGHTS:","length":11,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets","length":186,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99","length":196,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials","length":243,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating cash flow of $25.4 million with free cash flow of $15.4 million","length":73,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Ingevity widens its guidance range to reflect declines in industry forecasts of auto production due to trade tensions and tariff uncertainty; revised full year guidance of sales between $1.25 billion and $1.40 billion and adjusted EBITDA between $380 million and $415 million","length":275,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":973,"olType":false},{"type":"text","content":"The results and guidance in this release include non-GAAP financial measures. Refer to the section entit...

More updates from Ingevity Corporation